Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Fetal porcine cells, Neurocell-PD · 1 trial · 1 indication
| Name | Type | Description |
|---|---|---|
| Fetal porcine cells, Neurocell-PD | DRUG | - |
Inclusion Criteria: * The patient has idiopathic Parkinson's disease. a) with bradykinesia and either rest tremor or rigidity, b) history of asymmetry of Parkinson's disease signs, c) history of progression of Parkinson's disease signs, d) no other suspected cause of Parkinson's disease, e) the pat...
Neurocell-PD is an investigational cell therapy being studied for the treatment of Parkinson's Disease. It consists of fetal porcine cells that are transplanted into patients. The therapy is currently in clinical development and has not been approved by regulatory authorities.
Neurocell-PD is a cell therapy that uses fetal porcine cells, which are intended to replace or support the function of dopamine-producing neurons in the brain. This approach aims to address the underlying cell loss associated with Parkinson's Disease.
Neurocell-PD is being developed by Sanofi, a global biopharmaceutical company listed on the stock exchange under the ticker symbol SNY. The company is conducting clinical trials to evaluate the safety and efficacy of this investigational therapy.
Neurocell-PD is in Phase 2 clinical development. A Phase 2 trial has been completed, and the therapy remains investigational. It is not yet approved for commercial use, and further studies may be needed to establish its safety and effectiveness.
Neurocell-PD has been studied in one completed Phase 2 clinical trial, identified as NCT00226460. This was a double-blind, randomized, controlled multi-center trial conducted in the United States, evaluating the safety and efficacy of transplanted fetal porcine cells in patients with Parkinson's Disease.
Neurocell-PD is a formulation of fetal porcine cells. The drug name refers to the specific therapeutic product being developed by Sanofi, which consists of these cells for transplantation in patients with Parkinson's Disease.